Background Providers often prescribe counseling and/or medications for tobacco cessation without considering patients' treatment preferences. Objective The primary aims of this study are to describe (1) the development of a discrete choice experiment (DCE) questionnaire designed to identify the attributes and levels of tobacco treatment that are most important to veterans; and (2) the decision-making process in choosing between hypothetical tobacco treatments.
Methods
We recruited current smokers who were already scheduled for a primary care appointment within a single Veterans Affairs (VA) healthcare system. Subjects were asked to rate the importance of selected treatment attributes and were interviewed during two rounds of pilot testing of initial DCE instruments. Key attributes and levels of the initial instruments were identified by targeted literature review; the instruments were iteratively revised after each round of pilot testing. Using a 'think aloud' approach, subjects were interviewed while completing DCE choice tasks. Constant comparison techniques were used to characterize the issues raised by subjects. Findings from the cognitive interviews were used to revise the initial DCE instruments. Results Most subjects completed the DCE questionnaire without difficulty and considered two or more attributes in choosing between treatments. Two common patterns of decision-making emerged during the cognitive interviews: (1) counting 'pros' and 'cons' of each treatment alternative; and (2) using a 'rule-out' strategy to eliminate a given treatment choice if it included an undesirable attribute. Subjects routinely discounted the importance of certain attributes and, in a few cases, focused primarily on a single 'must-have' attribute. Conclusion Cognitive interviews provide valuable insights into the comprehension and interpretation of DCE attributes, the decision processes used by veterans during completion of choice tasks, and underlying reasons for non'-compensatory decision-making.
Introduction
The prevalence of smoking is significantly higher in US veterans than in the general civilian population (adjusted odds ratio in men = 1.19, 95% confidence interval 1.11-1.26) [1, 2] , and approximately US$2.7 billion in costs to the US Veterans Health Administration (VHA) were attributable to the health effects of smoking in 2010 [3] . Despite the evidence that telephone counseling and pharmacotherapy significantly improve cessation rates [4, 5] , many veterans are reluctant to talk to a smoking cessation counselor [6] and many others prefer to quit 'cold turkey' without any medications [7] . In 2013, only 25.6% of veterans who currently used tobacco received guideline-recommended pharmacotherapy for smoking cessation [8] . Those who attempt to quit with medication frequently misunderstand and misuse pharmacotherapy, and often relapse secondary to medication non-adherence [9, 10] . Historically, providers have selected treatments for smoking cessation without involving patients in the decision-making process, despite the fact that clinicians may not be very good judges of patients' treatment preferences [11, 12] .
Patient-based preference models can inform VHA policy makers and operational partners about the utility of current and hypothetical treatment modalities in their ongoing efforts to develop more patient-centered cessation programs. In this regard, the discrete choice experiment (DCE) is a particularly well-suited methodology for exploring the relative importance of healthcare attributes in the context of a real-world decision and demonstrating how patients trade among attributes when choices are constrained by limited resources [13, 14] . In a DCE, participants are asked to select their preferred option in a series of hypothetical scenarios (choice sets). The DCE approach assumes that patients act rationally when selecting health services, i.e., they choose a particular option only if its utility is higher than the utility of the other options in a given choice set [15] . Moreover, the use of a DCE to assess preferences assumes that participants are engaged in completing the choice task, they understand the information presented, and they make their choices based on trade-offs between all attributes that are important to them (i.e., they demonstrate compensatory decision-making) [16, 17] .
In actuality, some patients routinely violate normative principles of rational decision-making [18] , construct their preferences 'on the fly' during completion of choice tasks [16, 19] , or use simplifying heuristics that increase measurement error [20] . Others make additional assumptions or consider external information and personal experience in making choices. This study describes our efforts to circumvent some of these problems in the development of DCE questionnaires to assess veterans' preferences for smoking cessation counseling and pharmacotherapy. In addition, this study provides qualitative insight into the decision-making processes used by US veterans in choosing between treatment alternatives, including the decision to opt out.
Methods
We used an exploratory sequential mixed methods design, in which qualitative data were primarily used to develop and improve quantitative instruments of cessation counseling and pharmacotherapy [21] . Our approach to DCE questionnaire development was informed by prior literature (Fig. 1) [15, 22, 23] . During stage 1, we focused on identifying key attributes and levels pertinent to tobacco treatment in the VHA, constructed DCE instruments, and pretested them to assess comprehension and response burden. During stage 2, we pilot tested the DCE instruments, conducted 'think aloud' interviews to explore participants' decision-making processes, and iteratively revised the instruments. In stage 3, updated DCE instruments will be administered to a larger sample of veterans in order to estimate part-worth utilities for treatment attributes/levels (quantitative component).
Development of Discrete Choice Experiment (DCE) Choice Sets
To prepare the initial DCE questionnaire (stage 1), the first author (DAK) conducted a targeted literature search in 2013 to identify key treatment attributes and levels of each attribute that have been used in similar studies of preferences for smoking cessation treatment [24, 25] or that have been described in US guidelines for smoking cessation counseling and pharmacotherapy [5] . The following search terms were used to find pertinent studies in the literature: (discrete choice experiment or conjoint analysis or patient preference) AND (smoking cessation or tobacco cessation or tobacco use disorder). The list of candidate attributes and levels was reviewed by a panel of study investigators (KRS, MP, MWVW, GG) and the final list was determined by consensus. We labeled these attributes and levels using lay language that captures the meaning of each concept [23] . Treatment attributes that met the following criteria were eligible for inclusion in the DCE questionnaire: (1) reflect potentially modifiable features of Veterans Affairs (VA) tobacco treatment; (2) are capable of being traded off; (3) are at least somewhat familiar to patients; (4) have minimal overlap in their meaning; and (5) do not perfectly predict individuals' choice in a deterministic manner [26, 27] . Levels were chosen to represent a realistic range over which participants were expected to make tradeoffs; the levels of each attribute were mutually exclusive and were limited to two to four per attribute [22] . In the case of continuous attributes, such as quit rates for pharmacotherapy, we used the results of pertinent meta-analyses to inform the selection of plausible levels [5, 28] . To promote compensatory decision-making, it was also important to select levels with a wide enough range to induce subjects to trade between attributes [20] . From this list of attributes/levels, we used the experimental-design macros in JMP Ò (version 9; SAS Institute, Cary, NC, USA) to select an efficient subset of all possible treatment scenarios to develop separate DCE choice sets for cessation counseling and pharmacotherapy (using a fractional factorial design) [29] . To estimate the independent effect of each attribute with a relatively high degree of precision (i.e., high statistical efficiency), we designed choice tasks that generally satisfied the criteria of orthogonality and level balance [30] . Specifically, we checked for orthogonality using factor analysis, eliminated any dominated alternatives, and checked for level balance by verifying that each level of each attribute occurred with equal (or near equal) frequency. To reduce task complexity, we allowed some attribute levels to be the same in the profiles being compared (i.e., attribute overlap) [31] . All choice tasks and survey questions were written at an eighth-grade reading level to maximize comprehension.
As absence of decision-relevant attributes can bias the results of a DCE study [15, 20, 32] , we used semi-structured interviews to explore issues and concepts related to tobacco treatment in VA primary care to identify attributes/ levels that may have been missed in our literature review (Electronic Supplementary Material Appendix 1). Compared with focus groups, in-depth interviews enabled study interviewers to spend more time with subjects and allowed each subject to discuss his/her experiences in greater depth [23] .
Recruitment and Sampling Strategy
We recruited active primary care patients in the Iowa City VA Healthcare System (Iowa City, IA, USA) who smoked at least one cigarette per day (on average) and planned to quit smoking within the next 6 months (18 and 30 patients Fig. 1 Stages of discrete choice experiment questionnaire development. DCE discrete choice experiment, VA Veterans Administration during stages 1 and 2, respectively). Eligible patients were randomized in a 1:1 ratio to either the cessation counseling or pharmacotherapy questionnaire. Veterans with altered mental status, acute medical decompensation, history of cognitive impairment (e.g., dementia), communication barrier (e.g., aphasia), and terminal illness were excluded. Current smokers were identified by chart review in advance of a scheduled clinic appointment, and were sent a letter of invitation describing the study and the elements of informed consent. A research assistant followed up by telephone, confirmed eligibility, and arranged a time for completion of the study questionnaire in the clinic around the time of an already scheduled primary care appointment.
Data Collection Procedures
Completing DCE choice tasks can be cognitively demanding [22] . Because of this and the characteristics of our patient population, we administered the study questionnaire using a pencil-and-paper format (rather than by mail, telephone, or internet survey) as it allowed the interviewer to intervene when more explanation was needed, answer questions, and document any difficulties the subject had in completing the choice sets. The number of choice sets was limited to 15, as respondents can generally manage up to 16 choice tasks before fatigue and boredom supervene [22, 33] . Interviews were conducted in a private examination room by a PhD anthropologist and an observer experienced in qualitative methodologies. In preparation for the DCE choice sets, subjects were asked to rate the overall importance of selected tobacco treatment attributes on a 5-point Likert scale [34] . In addition, a warm-up exercise was employed to familiarize subjects with the DCE procedure (e.g., choosing a cell phone plan) (Electronic Supplementary Material Appendix 2). During stage 1, we included a single choice set to test within-set monotonicity (i.e., to assess whether the subject chose a dominant treatment that included superior levels of all attributes). Non-monotonic choices may indicate that the subject misunderstood the treatment attributes. To assess the test-retest stability of treatment choices (also known as completeness), we included a duplicate choice set at the end of the DCE questionnaire. During stage 2, we assessed whether subjects' choices were consistently dominated by a single high-priority attribute [35] (in violation of the continuity axiom), and confirmed the presence of noncompensatory decision-making in the think aloud data (see Sect. 2.4).
During completion of the DCE questionnaire, the interviewer actively encouraged subjects to verbalize everything that went through their minds when completing the choice task ('think aloud' approach) [36] . If the subject stopped thinking aloud, the interviewer prompted him to reflect back on his choices after every second or third choice task; this approach minimizes unnecessary disruptions of the thinking process [37] . This form of cognitive interviewing also provides data on the relevance and clarity of questionnaire items [38] and can be used to assess whether subjects use complex decision strategies or simplifying heuristics (e.g., 'rules of thumb') [17] . The observer monitored completion time of the DCE questionnaire.
Qualitative Coding and Data Analysis
Two qualitative analysts analyzed the think aloud data to evaluate subjects' overall comprehension of, and any difficulties in completing, the choice tasks. Guided by prior think aloud studies in the literature [16, 39] , we constructed a provisional coding structure that was tested using a subset of three transcripts [40] . The coding structure was revised iteratively as new themes emerged. Each set of transcripts was coded by two independent analysts using constant comparison techniques [41, 42] and assessed for inter-rater agreement at two intervals (with a preset goal of greater than 80% for all themes) [43] . When agreement was less than 80%, all discrepancies were discussed until a consensus between coders was reached. We attained data saturation after coding the interviews of 30 subjects [44] . In reviewing the transcripts, analysts attempted to characterize the decision process that subjects used in making a treatment choice, and documented potential instances of non-compensatory decision making. We carefully evaluated 'opt-out' choices, which may indicate non-compensatory decision-making or implausible treatment options. Although some of these effects are impossible to prevent, our goal was to use the interview data to better understand the decision-making process and thereby minimize these problems when revising the DCE questionnaires.
Quantitative Data Analysis
Ratings of attribute importance were summarized by (1) mean and standard deviation; and (2) the proportion of subjects who rated the attribute as very or extremely important. We calculated intra-rater reliability for duplicate choice sets using the kappa statistic.
Results
Characteristics of the study sample are shown in Table 1 . Age and sex composition of the study sample were comparable to that of VA tobacco users nationally [45] , but study subjects were predominantly white. Compared to stage 1 subjects, those interviewed during stage 2 had worse self-reported health and a lower proportion had made a prior quit attempt. Overall, 71% of subjects had tried to quit previously with medication, and 23% had used cessation counseling or coaching.
Attribute Development

Rating Survey
We calculated the average rating for each attribute. Overall, patients valued the quality of the smoking cessation counselor's communication skills and a focus on problemsolving strategies most highly (Table 2 ). An emphasis on the patient's choice on when and how to quit was also highly rated (mean = 3.9 on a 1-5 scale, n = 48). With regard to pharmacotherapy, patients highly rated medications that effectively relieve cravings for tobacco (mean = 4.2), have a low risk of behavioral and physical side effects (mean = 4.2 and 4.1, respectively), and significantly increase the odds of quitting (mean = 4.0) ( Table 3 ).
Changes Between Stages 1 and 2 of the DCE
Each attribute was identified as 'most important' by at least one subject in stage 1. In preparation for stage 2, we made several minor revisions in item phrasing and shortened the description of certain attributes/levels to reduce cognitive burden (Tables 4 and 5 ). In the counseling DCE, for example, we sharpened the contrast between levels of 'communication skills' and 'counselor's thoroughness' by presenting subjects with a mutually exclusive choice ('always' vs. 'does not always'). In the medication DCE, we reworded some of the attributes to improve clarity and specificity. For example, 'cost for 3 months' was changed to 'copayment for 3 months course of drug therapy'. Interview procedures remained the same in both stages.
Changes Between Stages 2 and 3 of the DCE
Based on lessons learned during this stage, we included three levels for all counseling attributes (except for the autonomy item, which had two levels) in order to consider a greater range of options (e.g., peer counseling) and a wider range of levels for certain continuous attributes (e.g., quit rate) ( Table 4 ). In cognitive interviews, for example, several subjects felt that the difference between a 14 and 18% quit rate was not clinically important; thus, the final instrument included three levels with a 12% spread. Because some descriptors of frequency (e.g., usually) are potentially vague, we also added quantitative labels to improve clarity (e.g., more than half of the time). We also added two new attributes based on the results of the rating survey (e.g., emphasis on autonomy) and in response to feedback from our operational partner (Director of Tobacco and Health at the VHA Office of Public Health). We dropped one attribute (counselor's thoroughness) because of non-orthogonality with another attribute (counselor's communication skills) ( Table 4) . Self-rated health (% fair-poor) 22 47 Belief that you currently have smoking-related medical problem (%) 39 33 Belief that quitting smoking would improve your health (% quite a bit or extremely so) 72 67 The contemplation ladder assesses a smoker's readiness to quit on a continuum ranging from having no thoughts about quitting to being actively engaged in quitting (range 0-10)
Based on cognitive interviews, we also revised the medication DCE (Table 5 ). For example, several subjects indicated that taking a medication eight times daily was not an acceptable option. Instead of assessing the utility of dose frequency, we revised this attribute to reflect the underlying concept, i.e., the choice between a fixed dose or symptom-triggered dosing (or their combination). This attribute also tapped into subjects' stated desire for rapid relief of nicotine withdrawal symptoms. Moreover, we divided the side effects domain into two separate attributes: physical and behavioral. In addition, we estimated the excess risk of side effects relative to placebo based on data from EAGLES (Evaluating Adverse Events in a Global Smoking Cessation Study), which examined the safety of various smoking cessation medications in patients with and without psychiatric disorders [46] . We also expanded the range of copayments for drug therapy to reflect the cost of possible combination therapy and because several subjects had indicated that the difference between levels in stage 2 was relatively unimportant. The final attributes and levels to be assessed in stage 3 are shown in Tables 4 and 5 , and sample choices sets are shown in Electronic Supplementary Material Appendix 3.
Findings from Stages 1 and 2
The first two iterations of the DCE questionnaire identified several attributes of tobacco treatment that were found to be important to subjects on the rating survey. With regard to counseling, it seemed clear that 'always listening' was critically important and emphasized the importance of building rapport; the type of counselor (clinician vs. nonclinician) and his/her familiarity with the patient did not seem to be important. Subjects preferred telephone counseling mostly because of convenience, but some patients felt that ''it would be better in person because then that way the person knows if you're B.S.-in' 'em'' (Subject 110). With regard to medication, subjects tended to focus on quit rate and side effects; other factors, such as copayment, were regarded as secondary concerns.
Insights Related to DCE Administration and Decision Processes
The first part of this section focuses on issues related to comprehension and intra-rater reliability. In the remainder of the section, we have grouped subjects' quotes from the think aloud interviews into two categories: (1) general issues related to completion of the DCE questionnaire; and (2) decision-making processes.
Monotonicity, Completeness, and NonCompensatory Decision-Making
We assessed within-set monotonicity in stage 1: 100% of subjects selected the dominant choice set in both DCE questionnaires. For the counseling DCE, intra-rater agreement for duplicate choice sets was 56 and 60% in stages 1 and 2; the corresponding values of kappa were 0.23 and 0.21, respectively. For the medication DCE, intra-rater agreement was 78 and 80%, but kappa improved significantly (from 0.50 to 0.70, respectively), suggesting that preferences for medication treatment were more stable during stage 2. During stage 2, five subjects demonstrated single-attribute non-compensatory decisionmaking (17%, confirmed by the think aloud data).
General Issues
Mean completion times for the counseling and medication DCE questionnaires during stage 1 were 21 and 18 min; the corresponding times during stage 2 were 26 and 17 min, respectively. Most subjects (S) completed the DCE questionnaire without difficulty; however, not all subjects were fully engaged, and in some cases the interviewer (I) documented signs of cognitive overload or exhaustion.
In a few cases, subjects struggled with the idea of choosing between two hypothetical medications, as shown in the following example: 
I2:
Yeah, mm-hmm…These aren't actual treatment plans that we're gonna ask you to pick from now.
(Subject 111)
In other cases, the subject questioned the veracity of the values (levels) used in the DCE questionnaire, or asked the interviewer for clarification of the meaning of attributes or levels used in the experiment. For example, the following subject appeared to misread the numerical information pertaining to side effects in the medication DCE: Well you would check neither.
[laughter] S Because these, these here, you know, on the other page they was over here.
I:
So-S: You can't-go ahead.
Okay. So, imagine that the other page just didn't even exist. Each page is taken in isolation but it's the same scenario. (Subject 119) Added new attribute based on feedback from operational partner and input from patients. Some subjects felt that a combination of face-to-face counseling and follow-up checks (using various modes of communication) would be optimal:
I: Um, would you prefer face-to-face or over the phone?
S: Uh, actually a combination of both.
I: OK. So, what would that look like?
S: Well it would probably have to start with a face-to-face, um, and in between face-to-face visits, uh, you know, phone calls, uh, emails, texts, whatever. (Subject 113) I interviewer, S subject, VA Veterans Administration 
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Some subjects highlighted the importance of behavioral side effects, as in the following example: For several patients, the difference between the initial levels of copayment was considered to be unimportant, as in the following example:
''I'm not real concerned with the copayments on this [US$0 vs. US$24]…I mean, if anybody wants to quit, I don't think they'd be concerned either.'' (Subject 128)
Quit rate at 1 year Expanded range of quit rates, consistent with current evidence 12% 10% 18% 16%
24% 22%
I interviewer, S subject Table 6 Examples of decision processes during completion of discrete choice experiment choice tasks Pertinent code (attribute) Selected quotes Counting S: Convenience-face-to-face versus counselling by telephone: I like counseling by phone. Familiarity with the counselor-doesn't make a difference. Type-clinical versus non-clinical: Doesn't make a difference. Format-would rather do group. Thoroughness-always considers smoking cessation. It's more preferred than doesn't consider. Follow-up-prefer two to three but that's not an option so I'll say three. Quit rate-higher percentage. 
Decision-Making Processes
Most subjects showed good comprehension of the choice tasks and clearly considered two or more attributes in choosing between medications. Two common patterns of decision-making emerged during the cognitive interviews:
(1) counting 'pros' and 'cons' of each treatment alternative; and (2) using a 'rule-out' strategy to eliminate a given treatment choice if it included an undesirable attribute ( Table 6 ). Use of the former strategy compared treatment options by simply counting the number of preferred attributes within each alternative, as exemplified by the following: In another case, the subject explicitly described weighing the attributes' relative importance in addition to counting 'pros' and 'cons':
I:
Okay, why A. S: More options that I like. I like these three. But these have more options that I like and the options that I like are more important. So I would have to go with A on this one. (Subject 119)
Subjects routinely discounted the importance of certain attributes, as in the following example: ''I don't think telephone monitoring [of medication] would affect me one way or another, so it-,…uh, I would probably end up goin' with Plan A on this one.'' (Subject 122) Despite use of a counting heuristic (in which the desired attributes in a given treatment profile are simply tallied up, with equal weighting), some subjects were indifferent between the two treatment alternatives, resulting in a 'toss-up'. In a few cases, subjects zeroed in on a single attribute and were not willing to trade, regardless of the values of other attributes. For example, the following subject seemed to focus exclusively on the quit rate: ''Oh, on this one, it's still A. The, the quit rate is higher whether-, to me, it doesn't matter. If you really want to quit, that's, [I: Yeah.] that's your GOAL.'' (Subject 124) For the same subject, out-ofpocket cost became a key determinant of choice when quit rate was held constant across treatments: ''And, on this one… I'd have to go with A. There's no cost. Quit rate's the same… Just want to quit smokin', but I want to be cheap, too.'' (Subject 124)
Several patients used a 'rule-out' strategy to eliminate a given treatment choice if it included an undesirable attribute ('deal breaker'). For example, one subject felt strongly that the counselor's communication skills were an essential attribute of good cessation counseling and had already determined his desired level of this attribute. In this scenario, the subject had clear preferences as he read through the attributes until he reached the point where options A and B offered the same attribute for communication skills:
''For follow-up, Option A. They're both equal. I would choose Option A. And the quit rate, Option A,'cause [of] the greater rate, but [long pause] they both don't listen to me so (laughter)…mmm…neither one of them listen to me… If I had to choose, I would prefer neither. I would prefer neither [long pause]. Even though that one gotta a better success rate, he still ain't gonna listen to me.'' (Subject 106)
There was also evidence that subjects' choices were influenced by prior experience with specific treatments or broader perceptions of the treatment context (see example in Table 6 ).
Discussion
Challenges faced by the VA population with regard to quitting tobacco include socioeconomic deprivation, a high burden of medical and psychiatric co-morbidities [47] , and a military culture that historically has normalized tobacco use [48, 49] . This study demonstrates the value of using qualitative methods to develop a DCE questionnaire to explore the preferences of veterans regarding smoking cessation treatment. Our findings also illustrate the importance of piloting treatment attributes and giving clear instructions on completion of choice tasks [23, 50] . Cognitive interviewing provided valuable insights into the comprehension and interpretation of DCE attributes, the I interviewer, S subject decision processes used by subjects during completion of choice tasks, and the underlying reasons for non-compensatory decision-making and 'opt-out' choices. Regarding the latter, we found that qualitative analysis revealed strong preferences for (or aversion to) particular treatment attributes. These findings can facilitate interpretation of DCE results, as it may not always be clear from the choice data what subjects assume about the opt-out alternative [20] . Although this study focused on smoking cessation treatment, our approach can be used to assess face and content validity of DCE choice sets more generally [51] . This study highlights some of the practical issues related to the use of DCE to assess patient preferences. Although comprehension of the DCE task was generally good, subjects may misinterpret quantitative risk information, which may be aggravated by lack of numeracy skills [52, 53] . A few subjects were observed to rush through the questionnaire without carefully considering the treatment options or avoided difficult choices by opting out. Others struggled to engage because choice tasks were hypothetical and they may have had difficulty conceptualizing treatments with which they had little prior experience. This may explain why intra-rater reliability for cessation counseling was relatively low during pilot testing. Furthermore, the responses used to assess stability can be noisy, as subjects attempt to understand the choice task (first choice set) and as fatigue sets in (last choice set) [54] . Indeed, we observed that subjects tended to learn which attributes/ levels were most important to them during the process of completing the initial choice sets.
There was clear evidence that most subjects weighed the trade-offs between multiple attributes; however, a few individuals made choices based on a single attribute, as reported by others [55, 56] , or used other simplifying heuristics. This form of non-compensatory decision-making may reflect a truly dominant preference for a single attribute (in violation of the continuity axiom) or it may reflect how some patients deal with a complex choice task. With regard to the latter, some individuals tend to be 'maximizers' who are inclined to invest substantial cognitive effort into determining the best treatment option, whereas others are 'satisficers' who tend to select the treatment option that is 'good enough' with the least possible effort [57] . Time pressure, task complexity, motivation, mode of administration, and prior experience with the treatment or service in question have also been shown to influence the use of heuristics to simplify choice tests [56, 58, 59] . Pretesting of the DCE questionnaire is recommended to ensure comprehension of the choice tasks, assess whether the response burden is acceptable, and ultimately reduce the use of simplifying heuristics. We also believe that having a researcher present during administration of the DCE increases the quality of the data collected.
This study has several limitations that warrant discussion. First, even though subjects were prompted to think aloud during completion of the DCE questionnaire, they showed varying levels of engagement and did not always articulate their reasons for making a particular treatment choice. Indeed, some subjects verbalized only considering a single attribute for a particular choice set, but individual utility models suggest that these same subjects in fact considered multiple attributes during the process of selecting treatment (data not shown). Second, we were unable to determine from the think aloud data the extent to which specific biases (e.g., halo effects, memory effects) may have influenced treatment selection. Third, we did not assess health literacy (or numeracy), which may affect subjects' comprehension of the DCE attributes and their likelihood of trading off between multiple attributes [17] . Fourth, the test of within-set monotonicity that we used in stage 1 can be relatively easily passed by chance alone [54] . In addition, the use of a single duplicate choice set may not have accurately captured the global test-retest stability of patient preferences in our study sample [51] . Cognitive interviews provided unique insight into the participant's reasoning and complemented these quantitative tests of choice validity and reliability. Fifth, we selected subjects who were contemplating cessation or actively preparing to quit; level of engagement in the DCE choice tasks would likely be lower in subjects who are less ready to quit. Sixth, for logistical reasons we recruited a convenience sample of study subjects who were already scheduled for a primary care visit. Use of maximum variation sampling may have allowed us to explore further how treatment selection varied across specific patient characteristics or prior experience. Finally, we recruited a convenience sample of subjects from a single VA healthcare system in the Midwest; subjects' use of language and comprehension of the study instruments may differ in other parts of the country.
Conclusions
This study demonstrates the feasibility of using DCE methods to elicit the preferences of veterans for smoking cessation treatment, and provides guidance for other investigators about the role of qualitative methods in developing DCE instruments. Qualitative work at the outset of this project provided a deeper understanding of the treatment context and confirmed the relevance of attributes that were derived from the literature and clinical experience, while later work helped to refine attribute/level descriptors to ensure that their intended meaning was conveyed [23] . In particular, cognitive interviews enabled the study team to assess comprehension and interpretation of DCE attributes, the decision processes used by veterans during completion of choice tasks, and underlying reasons for non-compensatory decision-making. Future research should explore the use of DCEs to provide real-time feedback on the relative importance of treatment attributes to individual patients and their clinicians, facilitate shared decision-making in the clinic, and develop new tobacco treatment programs that are informed by veterans' preferences.
